文献库，生知库 | 链接生命科学的每一步

Seaton, Melanie; Harbach, Sarah; Oke, Joanne; Walker, Thomas D J; Dalton-O'Reilly, Jessica; Selley, Julian; Brison, Daniel R; Bolton, James; Meyer, Stefan; Knight, David; Edmondson, Richard J; Schmidt, Christine K

肿瘤

肿瘤免疫

卵巢癌

发表日期：2026

文献求助收藏

Germline BRCA1/2 status and chemotherapy response score in high-grade serous ovarian cancer

高级别浆液性卵巢癌中生殖系BRCA1/2状态和化疗反应评分

期刊:British Journal of Cancer

影响因子:6.8

doi:10.1038/s41416-024-02874-6

Morgan, Robert D; Wang, Xin; Barnes, Bethany M; Spurgeon, Laura; Carrot, Aurore; Netto, Daniel; Hasan, Jurjees; Mitchell, Claire; Salih, Zena; Desai, Sudha; Shaw, Joseph; Winter-Roach, Brett; Schlecht, Helene; Burghel, George J; Clamp, Andrew R; Edmondson, Richard J; You, Benoit; Evans, D Gareth R; Jayson, Gordon C; Taylor, Stephen S

Correction: Combination treatment with rucaparib (Rubraca) and MDM2 inhibitors, Nutlin-3 and RG7388, has synergistic and dose reduction potential in ovarian cancer

更正：在卵巢癌治疗中，rucaparib（Rubraca）与MDM2抑制剂Nutlin-3和RG7388联合治疗具有协同作用和降低剂量的潜力。

期刊:Oncotarget

影响因子:

doi:10.18632/oncotarget.28523

Zanjirband, Maryam; Curtin, Nicola; Edmondson, Richard J; Lunec, John

Is Reflex Germline BRCA1/2 Testing Necessary in Women Diagnosed with Non-Mucinous High-Grade Epithelial Ovarian Cancer Aged 80 Years or Older?

对于 80 岁或以上被诊断患有非粘液性高级别上皮性卵巢癌的女性，是否有必要进行反射性生殖系 BRCA1/2 检测？

期刊:Cancers

影响因子:4.4

doi:10.3390/cancers15030730

Morgan, Robert D; Burghel, George J; Flaum, Nicola; Bulman, Michael; Smith, Philip; Clamp, Andrew R; Hasan, Jurjees; Mitchell, Claire L; Salih, Zena; Woodward, Emma R; Lalloo, Fiona; Crosbie, Emma J; Edmondson, Richard J; Schlecht, Helene; Jayson, Gordon C; Evans, D Gareth R

BRCA1/2 in non-mucinous epithelial ovarian cancer: tumour with or without germline testing?

非黏液性上皮性卵巢癌中的 BRCA1/2：是否需要进行生殖系检测？

期刊:British Journal of Cancer

影响因子:6.8

doi:10.1038/s41416-022-01773-y

Morgan, Robert D; Burghel, George J; Flaum, Nicola; Bulman, Michael; Smith, Philip; Clamp, Andrew R; Hasan, Jurjees; Mitchell, Claire L; Salih, Zena; Woodward, Emma R; Lalloo, Fiona; Crosbie, Emma J; Edmondson, Richard J; Wallace, Andrew J; Jayson, Gordon C; Evans, D Gareth R

Cervical cancer and COVID-an assessment of the initial effect of the pandemic and subsequent projection of impact for women in England: A cohort study

宫颈癌与新冠肺炎——对疫情初期影响的评估及对英格兰女性后续影响的预测：一项队列研究

期刊:Bjog-An International Journal of Obstetrics and Gynaecology

影响因子:4.3

doi:10.1111/1471-0528.17098

Davies, Jennifer M; Spencer, Alice; Macdonald, Sian; Dobson, Lucy; Haydock, Emily; Burton, Holly; Angelopoulos, Georgios; Martin-Hirsch, Pierre; Wood, Nick J; Thangavelu, Amudha; Hutson, Richard; Munot, Sarika; Flynn, Marina; Smith, Michael; DeCruze, Bridget; Myriokefalitaki, Eva; Sap, Katelijn; Winter-Roach, Brett; Macdonald, Robert; Edmondson, Richard J

Comparison of two questionnaires to diagnose obstructive defecation syndrome during pregnancy and post-natally

比较两种用于诊断妊娠期和产后梗阻性排便综合征的问卷

期刊:International Urogynecology Journal

影响因子:1.8

doi:10.1007/s00192-022-05114-8

Sentance, Joanne; Stocking, Katie; Edmondson, Richard J; Kearney, Rohna

发表日期：2022

文献求助收藏

Specialist oncological surgery for removal of the ovaries and fallopian tubes in BRCA1 and BRCA2 pathogenic variant carriers may reduce primary peritoneal cancer risk to very low levels

对于携带 BRCA1 和 BRCA2 致病性变异的患者，通过肿瘤专科手术切除卵巢和输卵管，可将原发性腹膜癌的风险降低至极低水平。

期刊:International Journal of Cancer

影响因子:4.7

doi:10.1002/ijc.33378

Crosbie, Emma J; Flaum, Nicola; Harkness, Elaine F; Clayton, Richard D; Holland, Cathrine; Martin-Hirsch, Pierre; Wood, Nick; Keating, Patrick; Woodward, Emma R; Lalloo, Fiona; Donnai, Paul; Edmondson, Richard J; Evans, D Gareth

Molecular Classification of the PORTEC-3 Trial for High-Risk Endometrial Cancer: Impact on Prognosis and Benefit From Adjuvant Therapy

PORTEC-3试验中高危子宫内膜癌的分子分型：对预后和辅助治疗获益的影响

期刊:Journal of Clinical Oncology

影响因子:41.9

doi:10.1200/JCO.20.00549

León-Castillo, Alicia; de Boer, Stephanie M; Powell, Melanie E; Mileshkin, Linda R; Mackay, Helen J; Leary, Alexandra; Nijman, Hans W; Singh, Naveena; Pollock, Pamela M; Bessette, Paul; Fyles, Anthony; Haie-Meder, Christine; Smit, Vincent T H B M; Edmondson, Richard J; Putter, Hein; Kitchener, Henry C; Crosbie, Emma J; de Bruyn, Marco; Nout, Remi A; Horeweg, Nanda; Creutzberg, Carien L; Bosse, Tjalling

Engineering microrobots for targeted cancer therapies from a medical perspective

从医学角度研究用于靶向癌症治疗的微型机器人工程

期刊:Nature Communications

影响因子:15.7

doi:10.1038/s41467-020-19322-7

Schmidt, Christine K; Medina-Sánchez, Mariana; Edmondson, Richard J; Schmidt, Oliver G

Fallopian tube lavage sampling towards early detection of pre-invasive ovarian cancer

输卵管灌洗取样用于早期发现癌前卵巢癌

Germline BRCA1/2 status and chemotherapy response score in high-grade serous ovarian cancer

高级别浆液性卵巢癌中生殖系BRCA1/2状态和化疗反应评分

Correction: Combination treatment with rucaparib (Rubraca) and MDM2 inhibitors, Nutlin-3 and RG7388, has synergistic and dose reduction potential in ovarian cancer

更正：在卵巢癌治疗中，rucaparib（Rubraca）与MDM2抑制剂Nutlin-3和RG7388联合治疗具有协同作用和降低剂量的潜力。

Is Reflex Germline BRCA1/2 Testing Necessary in Women Diagnosed with Non-Mucinous High-Grade Epithelial Ovarian Cancer Aged 80 Years or Older?

对于 80 岁或以上被诊断患有非粘液性高级别上皮性卵巢癌的女性，是否有必要进行反射性生殖系 BRCA1/2 检测？

BRCA1/2 in non-mucinous epithelial ovarian cancer: tumour with or without germline testing?

非黏液性上皮性卵巢癌中的 BRCA1/2：是否需要进行生殖系检测？

Cervical cancer and COVID-an assessment of the initial effect of the pandemic and subsequent projection of impact for women in England: A cohort study

宫颈癌与新冠肺炎——对疫情初期影响的评估及对英格兰女性后续影响的预测：一项队列研究

Comparison of two questionnaires to diagnose obstructive defecation syndrome during pregnancy and post-natally

比较两种用于诊断妊娠期和产后梗阻性排便综合征的问卷

Specialist oncological surgery for removal of the ovaries and fallopian tubes in BRCA1 and BRCA2 pathogenic variant carriers may reduce primary peritoneal cancer risk to very low levels

对于携带 BRCA1 和 BRCA2 致病性变异的患者，通过肿瘤专科手术切除卵巢和输卵管，可将原发性腹膜癌的风险降低至极低水平。

Molecular Classification of the PORTEC-3 Trial for High-Risk Endometrial Cancer: Impact on Prognosis and Benefit From Adjuvant Therapy

PORTEC-3试验中高危子宫内膜癌的分子分型：对预后和辅助治疗获益的影响

Engineering microrobots for targeted cancer therapies from a medical perspective

从医学角度研究用于靶向癌症治疗的微型机器人工程